These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37084305)

  • 41. The Importance of Glycosylation in COVID-19 Infection.
    Petrović T; Lauc G; Trbojević-Akmačić I
    Adv Exp Med Biol; 2021; 1325():239-264. PubMed ID: 34495539
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structure-function relations of the SARS-CoV-2 spike protein and impact of mutations in the variants of concern.
    Rey F
    C R Biol; 2021 Jun; 344(1):77-110. PubMed ID: 34213849
    [TBL] [Abstract][Full Text] [Related]  

  • 43. COVID-19 Coronavirus spike protein analysis for synthetic vaccines, a peptidomimetic antagonist, and therapeutic drugs, and analysis of a proposed achilles' heel conserved region to minimize probability of escape mutations and drug resistance.
    Robson B
    Comput Biol Med; 2020 Jun; 121():103749. PubMed ID: 32568687
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Emergence, evolution, and vaccine production approaches of SARS-CoV-2 virus: Benefits of getting vaccinated and common questions.
    Hassanin AA; Haidar Abbas Raza S; Ahmed Ujjan J; Aysh ALrashidi A; Sitohy BM; Al-Surhanee AA; Saad AM; Mohamed Al-Hazani T; Osman Atallah O; Al Syaad KM; Ezzat Ahmed A; Swelum AA; El-Saadony MT; Sitohy MZ
    Saudi J Biol Sci; 2022 Apr; 29(4):1981-1997. PubMed ID: 34924802
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MutCov: A pipeline for evaluating the effect of mutations in spike protein on infectivity and antigenicity of SARS-CoV-2.
    Zhou W; Xu C; Luo M; Wang P; Xu Z; Xue G; Jin X; Huang Y; Li Y; Nie H; Jiang Q; Anashkina AA
    Comput Biol Med; 2022 Jun; 145():105509. PubMed ID: 35421792
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SARS-CoV-2: Emergence of New Variants and Effectiveness of Vaccines.
    Singh DD; Parveen A; Yadav DK
    Front Cell Infect Microbiol; 2021; 11():777212. PubMed ID: 34970509
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Making sense of spike D614G in SARS-CoV-2 transmission.
    Shi AC; Xie X
    Sci China Life Sci; 2021 Jul; 64(7):1062-1067. PubMed ID: 33587268
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nanovaccine: A Hope to Triumph the Battle Against Novel Coronavirus Disease 2019 (COVID-19).
    Singh AK; Maurya A; Mishra G; Awasthi R; Dua K; Kulkarni GT
    Recent Pat Nanotechnol; 2023; 17(1):15-17. PubMed ID: 34303337
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A So-Far Overlooked Secondary Conformation State in the Binding Mode of SARS-CoV-2 Spike Protein to Human ACE2 and Its Conversion Rate Are Crucial for Estimating Infectivity Efficacy of the Underlying Virus Variant.
    Sevenich M; van den Heuvel J; Gering I; Mohrlüder J; Willbold D
    J Virol; 2022 Jul; 96(13):e0068522. PubMed ID: 35674432
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insights into the structural and dynamical changes of spike glycoprotein mutations associated with SARS-CoV-2 host receptor binding.
    Ahamad S; Kanipakam H; Gupta D
    J Biomol Struct Dyn; 2022 Jan; 40(1):263-275. PubMed ID: 32851910
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights.
    Divani AA; Andalib S; Di Napoli M; Lattanzi S; Hussain MS; Biller J; McCullough LD; Azarpazhooh MR; Seletska A; Mayer SA; Torbey M
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104941. PubMed ID: 32689643
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation.
    Cheng MH; Zhang S; Porritt RA; Noval Rivas M; Paschold L; Willscher E; Binder M; Arditi M; Bahar I
    Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25254-25262. PubMed ID: 32989130
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine.
    Tai W; He L; Zhang X; Pu J; Voronin D; Jiang S; Zhou Y; Du L
    Cell Mol Immunol; 2020 Jun; 17(6):613-620. PubMed ID: 32203189
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SARS-CoV-2 attachment to host cells is possibly mediated via RGD-integrin interaction in a calcium-dependent manner and suggests pulmonary EDTA chelation therapy as a novel treatment for COVID 19.
    Dakal TC
    Immunobiology; 2021 Jan; 226(1):152021. PubMed ID: 33232865
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Computational Alanine Scanning and Structural Analysis of the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Complex.
    Laurini E; Marson D; Aulic S; Fermeglia M; Pricl S
    ACS Nano; 2020 Sep; 14(9):11821-11830. PubMed ID: 32833435
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunogenicity and tolerability of COVID-19 messenger RNA vaccines in primary immunodeficiency patients with functional B-cell defects.
    Pham MN; Murugesan K; Banaei N; Pinsky BA; Tang M; Hoyte E; Lewis DB; Gernez Y
    J Allergy Clin Immunol; 2022 Mar; 149(3):907-911.e3. PubMed ID: 34952033
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exploring Spike Protein as Potential Target of Novel Coronavirus and to Inhibit the Viability Utilizing Natural Agents.
    Nandi S; Roy H; Gummadi A; Saxena AK
    Curr Drug Targets; 2021; 22(17):2006-2020. PubMed ID: 33687893
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Severe Acute Respiratory Syndrome Type 2-Causing Coronavirus: Variants and Preventive Strategies.
    Aydogdu MO; Rohn JL; Jafari NV; Brako F; Homer-Vanniasinkam S; Edirisinghe M
    Adv Sci (Weinh); 2022 Apr; 9(11):e2104495. PubMed ID: 35037418
    [TBL] [Abstract][Full Text] [Related]  

  • 59. How Do Anti-SARS-CoV-2 mRNA Vaccines Protect from Severe Disease?
    Federico M
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142284
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional and Structural Characterization of SARS-Cov-2 Spike Protein: An
    Ebrahim-Saraie HS; Dehghani B; Mojtahedi A; Shenagari M; Hasannejad-Bibalan M
    Ethiop J Health Sci; 2021 Mar; 31(2):213-222. PubMed ID: 34158771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.